Neuroprotective effect through the cerebral sodium-glucose transporter on the development of ischemic damage in global ischemia

Brain Research

Volumn 1541, Issue , 2013, Pages 61-68

  Harada, Shinichi ^a   Yamazaki, Yui ^a   Nishioka, Hiroki ^a   Tokuyama, Shogo ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Global ischemia; Glucose transporter; Hyperglycemia; Neuroprotection; SGLT

Indexed keywords

GLUCOSE; PHLORIZIN; SODIUM GLUCOSE COTRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEPOLARIZATION; DIABETES MELLITUS; DRUG EFFECT; GAIT; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPERGLYCEMIA; MALE; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL LESION; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR;

MUS;

GLOBAL ISCHEMIA; GLUCOSE TRANSPORTER; HYPERGLYCEMIA; NEUROPROTECTION; SGLT;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; MALE; MICE; NEUROPROTECTIVE AGENTS; PHLORHIZIN; SODIUM-GLUCOSE TRANSPORT PROTEINS;

EID: 84888012717     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.09.041     Document Type: Article

References (40)

1. K. Angeby-Moller, O.G. Berge, and F.P. Hamers Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: effects of morphine and rofecoxib J. Neurosci. Methods 174 2008 1 9
2. D. Burdakov, S.M. Luckman, and A. Verkhratsky Glucose-sensing neurons of the hypothalamus Philos. Trans. R. Soc. London B Biol. Sci. 360 2005 2227 2235
3. S.E. Capes, D. Hunt, K. Malmberg, P. Pathak, and H.C. Gerstein Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview Stroke 32 2001 2426 2432
4. P.L. Croxson, P.G. Browning, D. Gaffan, and M.G. Baxter Acetylcholine facilitates recovery of episodic memory after brain damage J. Neurosci. 32 2012 13787 13795
5. W.D. Dietrich, O. Alonso, and R. Busto Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats Stroke 24 1993 111 116
6. A. Diez-Sampedro, B.A. Hirayama, C. Osswald, V. Gorboulev, K. Baumgarten, C. Volk, E.M. Wright, and H. Koepsell A glucose sensor hiding in a family of transporters Proc. Natl. Acad. Sci. USA 100 2003 11753 11758
7. Y. Doi, T. Ninomiya, J. Hata, M. Fukuhara, K. Yonemoto, M. Iwase, M. Iida, and Y. Kiyohara Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study Stroke 41 2010 203 209
8. J.R. Ehrenkranz, N.G. Lewis, C.R. Kahn, and J. Roth Phlorizin: a review Diabetes Metab. Res. Rev. 21 2005 31 38
9. B. Fuentes, J. Castillo, B. San Jose, R. Leira, J. Serena, J. Vivancos, A. Davalos, A.G. Nunez, J. Egido, and E. Diez-Tejedor The prognostic value of capillary glucose levels in acute stroke: the glycemia in acute stroke (GLIAS) study Stroke 40 2009 562 568
10. C.S. Gray, J.F. Scott, J.M. French, K.G. Alberti, and J.E. O'Connell Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke Age Ageing 33 2004 71 77
11. S. Harada, W.H. Fujita, K. Shichi, and S. Tokuyama The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage Brain Res. 1279 2009 174 181
12. S. Harada, W. Hamabe, K. Kamiya, T. Satake, J. Yamamoto, and S. Tokuyama Preventive effect of Morinda citrifolia fruit juice on neuronal damage induced by focal ischemia Biol. Pharm. Bull. 32 2009 405 409
13. S. Harada, W. Fujita-Hamabe, and S. Tokuyama Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage J. Pharmacol. Sci. 115 2011 155 163
14. S. Harada, W. Fujita-Hamabe, and S. Tokuyama Ischemic stroke and glucose intolerance: a review of the evidence and exploration of novel therapeutic targets J. Pharmacol. Sci. 118 2012 1 13
15. S. Harada, Y. Yamazaki, and S. Tokuyama Orexin-A suppresses postischemic glucose intolerance and neuronal damage through hypothalamic brain-derived neurotrophic factor J. Pharmacol. Exp. Ther. 344 2013 276 285
16. R.K. Kinne, and F. Castaneda SGLT inhibitors as new therapeutic tools in the treatment of diabetes Handb. Exp. Pharmacol. 2011 105 126
17. R.N. Leao, S. Mikulovic, K.E. Leao, H. Munguba, H. Gezelius, A. Enjin, K. Patra, A. Eriksson, L.M. Loew, A.B. Tort, and K. Kullander OLM interneurons differentially modulate CA3 and entorhinal inputs to hippocampal CA1 neurons Nat. Neurosci. 15 2012 1524 1530
18. E.H. Lo, T. Dalkara, and M.A. Moskowitz Mechanisms, challenges and opportunities in stroke Nat. Rev. Neurosci. 4 2003 399 415
19. K. Matz, K. Keresztes, C. Tatschl, M. Nowotny, A. Dachenhausenm, M. Brainin, and J. Tuomilehto Disorders of glucose metabolism in acute stroke patients: an underrecognized problem Diabetes Care 29 2006 792 797
20. S.L. Mehta, N. Manhas, and R. Raghubir Molecular targets in cerebral ischemia for developing novel therapeutics Brain Res. Rev. 54 2007 34 66
21. C. Messier Glucose improvement of memory: a review Eur. J. Pharmacol. 490 2004 33 57
22. M.A. Moskowitz, E.H. Lo, and C. Iadecola The science of stroke: mechanisms in search of treatments Neuron 67 2010 181 198
23. M. Muranyi, and P.A. Li Hyperglycemia increases superoxide production in the CA1 pyramidal neurons after global cerebral ischemia Neurosci. Lett. 393 2006 119 121
24. D. O'Malley, F. Reimann, A.K. Simpson, and F.M. Gribble Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing Diabetes 55 2006 3381 3386
25. S. Park, S. Kim da, S. Kang, and D.Y. Kwon Ischemic hippocampal cell death induces glucose dysregulation by attenuating glucose-stimulated insulin secretion which is exacerbated by a high fat diet Life Sci. 88 2011 766 773
26. D.E. Pellegrini-Giampietro, J.A. Gorter, M.V. Bennett, and R.S. Zukin The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders Trends Neurosci. 20 1997 464 470
27. G. Perez Lopez, O. Gonzalez Albarran, and M. Cano Megias Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus Nefrologia 30 2010 618 625
28. R. Poppe, U. Karbach, S. Gambaryan, H. Wiesinger, M. Lutzenburg, M. Kraemer, O.W. Witte, and H. Koepsell Expression of the Na+-d-glucose cotransporter SGLT1 in neurons J. Neurochem. 69 1997 84 94
29. D. Sander, and M.T. Kearney Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives J. Neurol. 256 2009 1603 1619
30. A. Scheepers, H.G. Joost, and A. Schurmann The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function JPEN J. Parenter. Enteral Nutr. 28 2004 364 371
31. A. Shuaib, K.R. Lees, P. Lyden, J. Grotta, A. Davalos, S.M. Davis, H.C. Diener, T. Ashwood, W.W. Wasiewski, and U. Emeribe NXY-059 for the treatment of acute ischemic stroke N. Engl. J. Med. 357 2007 562 571
32. S. Tamiya, Y. Yoshida, S. Harada, K. Nakamoto, and S. Tokuyama Establishment of a central post-stroke pain model using global cerebral ischaemic mice J. Pharm. Pharmacol. 65 2013 615 620
33. S. Vemula, K.E. Roder, T. Yang, G.J. Bhat, T.J. Thekkumkara, and T.J. Abbruscato A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation J. Pharmacol. Exp. Ther. 328 2009 487 495
34. T. Watanabe, M. Tanaka, K. Watanabe, Y. Takamatsu, and A. Tobe Research and development of the free radical scavenger edaravone as a neuroprotectant Yakugaku Zasshi 124 2004 99 111
35. H. Widmer, H. Abiko, A.I. Faden, T.L. James, and P.R. Weinstein Effects of hyperglycemia on the time course of changes in energy metabolism and pH during global cerebral ischemia and reperfusion in rats: correlation of 1 H and 31 P NMR spectroscopy with fatty acid and excitatory amino acid levels J. Cereb. Blood Flow Metab. 12 1992 456 468
36. E.M. Wright Renal Na(+)-glucose cotransporters Am. J. Physiol. Renal Physiol. 280 2001 F10 18
37. E.M. Wright, and E. Turk The sodium/glucose cotransport family SLC5 Pflugers Arch 447 2004 510 518
38. T. Yamaguchi, E. Mori, K. Minematsu, J. Nakagawara, K. Hashi, I. Saito, and Y. Shinohara Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 h of onset: Japan Alteplase Clinical Trial (J-ACT) Stroke 37 2006 1810 1815
39. Y. Yamazaki, S. Harada, and S. Tokuyama Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter Brain Res. 1489 2012 113 120
40. P. Zimmet, K.G. Alberti, and J. Shaw Global and societal implications of the diabetes epidemic Nature 414 2001 782 787